Florencia González‐Lizárraga

National University of Tucumán — Argentina

Medicine · Health Sciences

11h-index518citations25works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(16), Parkinson's Disease Mechanisms and Treatments(15), Neuroinflammation and Neurodegeneration Mechanisms(10), Cholinesterase and Neurodegenerative Diseases(4), Botulinum Toxin and Related Neurological Disorders(3)

Publications25 total

Structure-Based Selection of a Tetracycline Derivative for Advanced Biosensor Platforms Targeting Aggregated α-Synuclein in Parkinson’s Disease
ACS Chemical Neuroscience·2026Open Access
Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin
Neuropathology and Applied Neurobiology·2025· 1 citedOpen Access
Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative
Biomolecules·2025· 2 citedOpen Access
Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson’s Disease
ACS Chemical Neuroscience·2024· 5 cited
Contribution of the Mitochondrial Complex I Inhibitor Annonacin to the Alpha-synuclein/Tau Co-pathology in Caribbean Atypical Parkinsonism (P2-3.010)
Neurology·2024
Magnetic amyloid-based biocatalyst for the hydrolysis of urea
Food Chemistry·2023· 1 cited
PAMAM dendrimers of generation 4.5 loaded with curcumin interfere with α-synuclein aggregation
OpenNano·2023· 11 citedOpen Access
Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives
Antioxidants·2023· 22 citedOpen Access
Magnetic Amyloid-Based Biocatalyst for the Hydrolysis of Urea
SSRN Electronic Journal·2023Open Access
Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
Cells·2022· 9 citedOpen Access
Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
Preprints.org·2022· 5 citedOpen Access
Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
2022· 2 cited
The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress
Cells·2021· 23 citedOpen Access
The non-antibiotic tetracycline COL-3 prevents microglial inflammatory responses by reducing glucose-mediated oxidative stress.
2021· 4 citedOpen Access
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
Frontiers in Aging Neuroscience·2021· 32 citedOpen Access
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Neurobiology of Disease·2021· 72 citedOpen Access
Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
2021
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
Scientific Reports·2020· 23 citedOpen Access
Doxycycline interferes with tau amyloid aggregation abolishing its associated neuronal toxicity
2020· 1 citedOpen Access
Doxycycline inhibits α-synuclein-associated pathologies <i>in vitro</i> and <i>in vivo</i>
2020· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Rosana Chehı́n(25), Rita Raisman‐Vozari(19), Patrick P. Michel(16), Sergio B. Socías(13), César L. Ávila(13), Elaine Aparecida Del Bel(12), Diego Ploper(11), Maurício dos Santos Pereira(8), Valeria Parrales(6), Tiago F. Outeiro(6), Annie Lannuzel(5), Bruno Figadère(5), Rodrigo Hernán Tomas‐Grau(5), Julia E. Sepúlveda-Díaz(4), Antonio Dominguez‐Meijide(4), Luciana Medina(4), Jean Michel Brunel(4), Laurent Ferrié(4), Silvina Chaves(4), Esteban Vera Pingitore(4)